Basket | Login | Register

 
 
 
 

AWARE (coming soon)

Phase II trials

Scientific title

A Study to Evaluate the Efficacy and Safety of ABBV-8E12 in Subjects With Early Alzheimer's Disease

Study sponsor

AbbVie

Disease

Early Alzheimer's Disease

Phase

Phase II

Name of drug

ABBV-8E12

Link to full text

https://clinicaltrials.gov/ct2/show/study/NCT02880956?term=8E12&show_locs=Y

Please note that an accessible easy read version of this study is not yet available. The pharmaceutical company running this trial and a member of the European Working Group of People with Dementia are currently reviewing this document.

 

 
 

Last Updated: Thursday 07 February 2019

 

 
  • Acknowledgements

    Alzheimer Europe's Clinical Trial Watch received funding under an operating grant from the European Union’s Health Programme (2014–2020).
  • European Union
 
 

Options